- Home
- ONCY vs NTZ Comparison
ONCY vs NTZ Comparison
Compare ONCY & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- NTZ
- Stock Information
- Founded
- ONCY 1998
- NTZ 1959
- Country
- ONCY Canada
- NTZ Italy
- Employees
- ONCY N/A
- NTZ N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- NTZ Home Furnishings
- Sector
- ONCY Health Care
- NTZ Consumer Discretionary
- Exchange
- ONCY Nasdaq
- NTZ Nasdaq
- Market Cap
- ONCY 53.6M
- NTZ 52.2M
- IPO Year
- ONCY 1999
- NTZ 1993
- Fundamental
- Price
- ONCY $0.56
- NTZ $4.91
- Analyst Decision
- ONCY Strong Buy
- NTZ
- Analyst Count
- ONCY 4
- NTZ 0
- Target Price
- ONCY $4.00
- NTZ N/A
- AVG Volume (30 Days)
- ONCY 224.8K
- NTZ 5.8K
- Earning Date
- ONCY 03-07-2025
- NTZ 04-08-2025
- Dividend Yield
- ONCY N/A
- NTZ N/A
- EPS Growth
- ONCY N/A
- NTZ N/A
- EPS
- ONCY N/A
- NTZ N/A
- Revenue
- ONCY N/A
- NTZ $365,846,531.00
- Revenue This Year
- ONCY N/A
- NTZ N/A
- Revenue Next Year
- ONCY N/A
- NTZ N/A
- P/E Ratio
- ONCY N/A
- NTZ N/A
- Revenue Growth
- ONCY N/A
- NTZ N/A
- 52 Week Low
- ONCY $0.55
- NTZ $3.80
- 52 Week High
- ONCY $1.53
- NTZ $6.43
- Technical
- Relative Strength Index (RSI)
- ONCY 27.91
- NTZ 58.34
- Support Level
- ONCY $0.58
- NTZ $4.39
- Resistance Level
- ONCY $0.65
- NTZ $5.20
- Average True Range (ATR)
- ONCY 0.03
- NTZ 0.19
- MACD
- ONCY -0.00
- NTZ 0.04
- Stochastic Oscillator
- ONCY 1.34
- NTZ 69.79
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.